Genus (LON:GNS – Get Free Report)‘s stock had its “buy” rating restated by analysts at Berenberg Bank in a note issued to investors on Tuesday, Digital Look reports. They currently have a GBX 3,350 price target on the stock. Berenberg Bank’s price objective suggests a potential upside of 44.15% from the company’s current price.
Genus Stock Performance
GNS stock opened at GBX 2,324 on Tuesday. The company has a market capitalization of £1.54 billion, a P/E ratio of 5.47, a PEG ratio of 2.87 and a beta of 0.90. The company has a 50-day simple moving average of GBX 2,230.35 and a 200 day simple moving average of GBX 2,277.85. Genus has a fifty-two week low of GBX 1,943 and a fifty-two week high of GBX 3,220. The company has a quick ratio of 1.08, a current ratio of 2.22 and a debt-to-equity ratio of 14.02.
Genus (LON:GNS – Get Free Report) last announced its earnings results on Thursday, September 10th. The company reported GBX 110.30 earnings per share (EPS) for the quarter. Genus had a net margin of 43.35% and a return on equity of 44.90%. Sell-side analysts predict that Genus will post 70.96 earnings per share for the current fiscal year.
Insider Buying and Selling at Genus
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Further Reading
- Five stocks we like better than Genus
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
